William B Feldman (William Feldman)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Drug Administration

Chronic Obstructive Pulmonary Disease

Molecular Dynamics Simulations

Top Venues

Annals of internal medicine

Clinical pharmacology and therapeutics

Pediatric blood & cancer

The Milbank quarterly

This page only lists publications with an associated author ORCID identifier.

Publications

Ian T T Liu, Junyi Wang, Ameet Sarpatwari, Aaron S Kesselheim, William B Feldman
Commercial markups on pediatric oncology drugs at 340B pediatric hospitals. Pediatric blood & cancer (2024)
Iselin Dahlen Syversen, Kevin Schulman, Aaron S Kesselheim, William B Feldman
A Comparative Analysis of International Drug Price Negotiation Frameworks: An Interview Study of Key Stakeholders. The Milbank quarterly (2024)
William B Feldman, Leah Zoe Gibson Rand, Daniel Carpenter, Massimiliano Russo, Anushka Bhaskar, Zhigang Lu, Eric G Campbell, Jonathan Darrow, Aaron S Kesselheim
Trust in the Food and Drug Administration: A National Survey Study. Clinical pharmacology and therapeutics 116 (2) (2024)
Ian T T Liu, Junyi Wang, Ameet Sarpatwari, Aaron S Kesselheim, William B Feldman
Commercial markups on pediatric oncology drugs at 340B pediatric hospitals. Pediatric blood & cancer 71 (9) (2024)
William B Feldman, Aaron S Kesselheim, Jerry Avorn, Massimiliano Russo, Shirley V Wang
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Annals of internal medicine 177 (1) (2024)
Matthew Vogel, Benjamin N Rome, Aaron S Kesselheim, William B Feldman
Medicare Negotiation's Drug Reformulation Problem. Annals of internal medicine 177 (6) (2024)
William B Feldman, Leah Zoe Gibson Rand, Daniel Carpenter, Massimiliano Russo, Anushka Bhaskar, Zhigang Lu, Eric G Campbell, Jonathan Darrow, Aaron S Kesselheim
Trust in the Food and Drug Administration: A National Survey Study. Clinical pharmacology and therapeutics 116 (2) (2024)
William B Feldman, Leah Zoe Gibson Rand, Daniel Carpenter, Massimiliano Russo, Anushka Bhaskar, Zhigang Lu, Eric G Campbell, Jonathan Darrow, Aaron S Kesselheim
Trust in the Food and Drug Administration: A National Survey Study. Clinical pharmacology and therapeutics (2024)
William B Feldman, Aaron S Kesselheim, Jerry Avorn, Massimiliano Russo, Shirley V Wang
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Annals of internal medicine 177 (1) (2024)
Ian T T Liu, Junyi Wang, Ameet Sarpatwari, Aaron S Kesselheim, William B Feldman
Commercial markups on pediatric oncology drugs at 340B pediatric hospitals. Pediatric blood & cancer 71 (9) (2024)
Matthew Vogel, Benjamin N Rome, Aaron S Kesselheim, William B Feldman
Medicare Negotiation's Drug Reformulation Problem. Annals of internal medicine 177 (6) (2024)
William B Feldman, Leah Zoe Gibson Rand, Daniel Carpenter, Massimiliano Russo, Anushka Bhaskar, Zhigang Lu, Eric G Campbell, Jonathan Darrow, Aaron S Kesselheim
Trust in the Food and Drug Administration: A National Survey Study. Clinical pharmacology and therapeutics 116 (2) (2024)
Matthew Vogel, Benjamin N Rome, Aaron S Kesselheim, William B Feldman
Medicare Negotiation's Drug Reformulation Problem. Annals of internal medicine (2024)
Anders Olsen, Reed F Beall, Ryan P Knox, S Sean Tu, Aaron S Kesselheim, William B Feldman
Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019. PLoS medicine 20 (11) (2023)
Edward Robert Scheffer Cliff, Aaron S Kesselheim, William B Feldman
Ensuring Ethical Postprogression Therapy for Patients in Randomized Trial Control Arms. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Edward Robert Scheffer Cliff, Amar H Kelkar, David A Russler-Germain, Frazer A Tessema, Adam J N Raymakers, William B Feldman, Aaron S Kesselheim
High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43 (2023)
William B Feldman, Aaron S Kesselheim, Jerry Avorn, Massimiliano Russo, Shirley V Wang
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Annals of internal medicine (2023)
Richard G Frank, Mahnum Shahzad, Aaron S Kesselheim, William B Feldman
Biosimilar competition: Early learning. Health economics 31 (4) (2022)
William B Feldman, Doni Bloomfield, Reed F Beall, Aaron S Kesselheim
Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD. Nature biotechnology 40 (9) (2022)
VÉronique C Raimond, William B Feldman, Benjamin N Rome, Aaron S Kesselheim
Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation. The Milbank quarterly 99 (1) (2021)
William B Feldman, Joshua J Gagne, Aaron S Kesselheim
Trends in Medicare Part D Inhaler Spending: 2012-2018. Annals of the American Thoracic Society 18 (3) (2021)